AGILON HEALTH INC (AGL)

US00857U1079 - Common Stock

5.19  +0.19 (+3.8%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.834B
50.50%		2.708B
47.70%		4.316B
59.38%		6.457B
49.59%
EBITDA
YoY % growth
-379.33M
-790.45%		-106.63M
71.89%		-211.972M
-98.79%		-25.558M
87.94%
EBIT
YoY % growth
-394M
-594.89%		-120.4M
69.44%		-232.133M
-92.80%		-174.261M
24.93%
Operating Margin
-21.49%-4.45%-5.38%-2.70%
EPS
YoY % growth
-1.07-0.26
75.70%		-0.49
-88.46%		-0.30
37.99%		N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.01
-129.85%
Revenue
Q2Q % growth		1.619B
42.51%
EBITDA
Q2Q % growth		17.038M
EBIT
Q2Q % growth		-9.249M
-246.81%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.41
-192.86%		-0.30-0.11-34.90%
Q3 2023
Q2Q % growth		 -0.08
-14.29%		-0.06-0.02-39.16%
Q2 2023
Q2Q % growth		 -0.04
20.00%		-0.03-0.01-55.98%
Q1 2023
Q2Q % growth		 0.04
∞%		0.020.0281.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 815.504M
18.22%		1.028B-212.496M-20.67%
Q3 2023
Q2Q % growth		 1.216B
74.95%		1.149B66.7M5.81%
Q2 2023
Q2Q % growth		 1.149B
71.48%		1.122B27.1M2.42%
Q1 2023
Q2Q % growth		 1.136B
73.88%		1.089B47.1M4.33%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-68.86% -159.1% -21.55% -262.1%
Revenue0% 3.32% -0.06% 2.8%